Recognition of Impairment Losses on Investment Securities
First written in FY2024-Q3. 3 of 6 entries say "Advanced", first in FY2024. Latest entry: FY2026.
The whole theme swung hardest in 2026: 35 of 80 companies on the "Worse" side.
52 other companies' latest entry also says "Other".
- FY2026Further decrease in impairment lossesAnnual report
「During the current consolidated fiscal year, the Company recognized impairment losses of ¥21.115 million on securities, comprising ¥21.115 million on shares classified as other securities.」
Impairment losses on investment securities decreased from ¥246.621 million in the previous fiscal year to ¥21.115 million, but impairment losses were still recorded in the current fiscal year. - FY2025Decrease in impairment lossesAnnual report
「During the current consolidated fiscal year, impairment losses on investment securities decreased to ¥246.621 million and impairment losses decreased to ¥276.266 million, respectively.」
Impairment losses on investment securities decreased from ¥690.861 million in the previous fiscal year to ¥246.621 million, but impairment losses were still recorded in the current fiscal year. - FY2025-H1AdvancedAnnual report
「Impairment losses on investment securities 49,990」
During the current interim consolidated accounting period, the Company recorded ¥49.990 million in impairment losses on investment securities as an extraordinary loss. This disclosure follows the recognition of impairment losses in the previous fiscal year. - FY2025-Q1AdvancedAnnual report
「Impairment Loss on Investment Securities」
During the first quarter of the current consolidated fiscal year, the Company recorded ¥49.990 million in impairment losses on investment securities as an extraordinary loss. The quarterly results disclose another recognition of impairment losses on investment securities following the previous fiscal year. - FY2024AdvancedAnnual report
「During the current consolidated fiscal year, the Company recorded ¥692.151 million in impairment losses on investment securities as an extraordinary loss.」
The Company recorded ¥692.151 million in impairment losses for the full fiscal year, compared with the ¥177.137 million disclosed through the previous quarter. - FY2024-Q3First statedAnnual report
「¥177.137 million in impairment losses on investment securities recorded as an extraordinary loss」
During the nine-month period of the current consolidated fiscal year, the Company recorded ¥177.137 million in impairment losses on investment securities as an extraordinary loss.